A detailed history of Aveo Capital Partners, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Aveo Capital Partners, LLC holds 923 shares of TMO stock, worth $476,434. This represents 0.06% of its overall portfolio holdings.

Number of Shares
923
Previous 903 2.21%
Holding current value
$476,434
Previous $499,000 14.23%
% of portfolio
0.06%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$531.86 - $624.21 $10,637 - $12,484
20 Added 2.21%
923 $570,000
Q2 2024

Aug 02, 2024

SELL
$541.52 - $599.02 $31,949 - $35,342
-59 Reduced 6.13%
903 $499,000
Q1 2024

May 06, 2024

BUY
$528.82 - $599.43 $77,207 - $87,516
146 Added 17.89%
962 $559,000
Q4 2023

Feb 06, 2024

BUY
$431.41 - $532.94 $31,061 - $38,371
72 Added 9.68%
816 $433,000
Q3 2023

Nov 06, 2023

BUY
$498.29 - $574.41 $14,948 - $17,232
30 Added 4.2%
744 $376,000
Q2 2023

Aug 08, 2023

BUY
$508.46 - $591.13 $12,203 - $14,187
24 Added 3.48%
714 $372,000
Q1 2023

May 03, 2023

BUY
$535.0 - $604.82 $40,125 - $45,361
75 Added 12.2%
690 $397,000
Q4 2022

Feb 03, 2023

BUY
$484.71 - $571.37 $74,645 - $87,990
154 Added 33.41%
615 $338,000
Q3 2022

Nov 09, 2022

SELL
$507.19 - $604.49 $15,722 - $18,739
-31 Reduced 6.3%
461 $234,000
Q2 2022

Aug 05, 2022

BUY
$500.9 - $612.21 $21,538 - $26,325
43 Added 9.58%
492 $267,000
Q1 2022

May 13, 2022

SELL
$524.0 - $644.92 $3,668 - $4,514
-7 Reduced 1.54%
449 $265,000
Q4 2021

Feb 11, 2022

SELL
$569.0 - $667.24 $10,811 - $12,677
-19 Reduced 4.0%
456 $304,000
Q3 2021

Nov 12, 2021

BUY
$509.53 - $609.78 $20,890 - $25,000
41 Added 9.45%
475 $271,000
Q2 2021

Aug 13, 2021

BUY
$441.0 - $508.24 $191,394 - $220,576
434 New
434 $219,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $202B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Aveo Capital Partners, LLC Portfolio

Follow Aveo Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aveo Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aveo Capital Partners, LLC with notifications on news.